A Phase 4 interventional study of L-arginine and Sildenafil in Thalassemia, sponsored by Sherief Abd-Elsalam. Status unknown at 1 site in Egypt. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2018-08-27.
Sponsored by Sherief Abd-Elsalam · Phase 4, Interventional, and Treatment
This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia
This study focuses on different lines of treatment for pulmonary hypertension in children with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in Children with Beta Thalassemia Associated with Pulmonary Hypertension
Exclusion Criteria:
l-arginine for pulmonary hypertension in patients with thalassemia.
Drug: L-arginine
Sildenafil for pulmonary hypertension in patients with thalassemia.
Drug: Sildenafil
No pulmonary hypertension
l-arginine for thalassemia with pulmonary hypertension
Sildenafil for thalassemia with pulmonary hypertension
Also known as: Viagra
Number of patients with improvement of pulmonary hypertension
patients with improvement of pulmonary hypertension
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sherief Abd-Elsalam